Serum albumin and α-1 acid glycoprotein impede the killing of Schistosoma mansoni by the tyrosine kinase inhibitor Imatinib.
Serum albumin and α-1 acid glycoprotein impede the killing of Schistosoma mansoni by the tyrosine kinase inhibitor Imatinib.
复制标题
DOI:
10.1016/j.ijpddr.2014.07.005
复制
发表时间:
2014-12
影响因子:
4
通讯作者:
Grevelding, Christoph G.
中科院分区:
文献类型:
--
作者:
Beckmann, Svenja;Long, Thavy;Scheld, Christina;Geyer, Rudolf;Caffrey, Conor R.;Grevelding, Christoph G.
关键词:
The Abl tyrosine-kinase inhibitor Imatinib is toxic to S. mansoni in vitro but not in vivo in rodents. Blood components like serum albumin and alpha-1 acid glycoprotein (AGP) negated Imatinib’s toxicity in vitro. Erythromycin partially restored the toxicity of Imatinib in vitro. High levels of AGP upon infection make rodents poor models for examining some small molecule inhibitors. In the search for new drugs and drug targets to treat the flatworm disease schistosomiasis, protein kinases (PKs) have come under particular scrutiny because of their essential roles in developmental and physiological processes in schistosome parasites. In this context the application of the anti-cancer Abl tyrosine kinase (TK) inhibitor Imatinib (Gleevec/Glivec; STI-571) to adult Schistosoma mansoni in vitro has indicated negative effects on diverse physiological processes including survival. Motivated by these in vitro findings, we performed in vivo experiments in rodent models of S. mansoni infection. Unexpectedly, Imatinib had no effect on worm burden or egg-production. We found that the blood components serum albumin (SA) and alpha-1 acid glycoprotein (AGP or orosomucoid) negated Imatinib’s deleterious effects on adult S. mansoni and schistosomula (post-infective larvae) in vitro. This negative effect was partially reversed by erythromycin. AGP synthesis can increase as a consequence of inflammatory processes or infection; in addition upon infection AGP levels are 6–8 times higher in mice compared to humans. Therefore, mice and probably other rodents are poor infection models for measuring the effects of Imatinib in vivo. Accordingly, we suggest the routine evaluation of the ability of AGP and SA to block in vitro anti-schistosomal effects of small molecules like Imatinib prior to laborious and expensive animal experiments.
登录
查看更多内容
影响因子:
6.7
作者:
Buro C;Oliveira KC;Lu Z;Leutner S;Beckmann S;Dissous C;Cailliau K;Verjovski-Almeida S;Grevelding CG
通讯作者:
Grevelding CG
DOI:
10.1164/rccm.200702-178oc
发表时间:
2007-12-15
影响因子:
24.7
作者:
Azuma, Momoyo;Nishioka, Yasuhiko;Sone, Saburo
通讯作者:
Sone, Saburo
影响因子:
8.1
作者:
Chen MG
通讯作者:
Chen MG
影响因子:
3.8
作者:
Buro C;Beckmann S;Oliveira KC;Dissous C;Cailliau K;Marhöfer RJ;Selzer PM;Verjovski-Almeida S;Grevelding CG
通讯作者:
Grevelding CG
影响因子:
13.5
作者:
Fabbro, D;Ruetz, S;Manley, PW
通讯作者:
Manley, PW